^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    nab-paclitaxel/rituximab nanoparticle (AR160)

    i
    Other names: AR160
    Company:
    Mayo Clinic, Sorrento
    Drug class:
    CD20 inhibitor, Tubulin inhibitor
    Related drugs: